SPONSORED CONTENT As I write this, we’re reaching the end of what’s “officially” LGBTQ+ Pride Month. The first Pride marches […]
SPONSORED CONTENT While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of […]
SPONSORED CONTENT As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important […]
SPONSORED CONTENT Artificial Intelligence (AI) is making significant strides in healthcare, and its potential impact on the 340B Drug Pricing […]
SPONSORED CONTENT In the complex landscape of healthcare, compliance with the Health Resources and Services Administration’s (HRSA) 340B program is […]
SPONSORED CONTENT Note: The Advanced 340B Operations Certificate Program is a separate Apexus offering that is not a part of […]
SPONSORED CONTENT On April 19, 2024—fourteen years after the Congressional deadline—the Health Resources and Services Administration published its final rule […]
SPONSORED CONTENT All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit […]
SPONSORED CONTENT The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program […]
SPONSORED CONTENT Since 2020, select drug manufacturers have begun deploying restrictions or limitations on the sale of their products through […]
